SCHEMBL2079696

SCHEMBL2079696

O=C(O)C=CC(=Cc1ccc(Cl)cc1Cl)c1ccc(Cl)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.44
MAPT P10636 4/20 0.44
ALDH1A1 P00352 3/20 0.44
KDM4E B2RXH2 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
GAA P10253 1/20 0.44
GABRA1 P14867 1/20 0.43
GABRG2 P18507 1/20 0.43
GABRB3 P28472 1/20 0.43
ITGB2 P05107 2/20 0.42
ICAM1 P05362 2/20 0.42
ITGAL P20701 2/20 0.42
TBXA2R P21731 1/20 0.42
PTGFR P43088 1/20 0.42
PTGER3 P43115 1/20 0.42
PTGER2 P43116 1/20 0.42
PTGIR P43119 1/20 0.42
PTGDR Q13258 1/20 0.42
PLA2G1B P04054 1/20 0.42
ATG4B Q9Y4P1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12784704 1.00 TDP1 (0.44) TDP1MAPTALDH1A1KDM4EL3MBTL1
SCHEMBL2079693 1.00 TDP1 (0.44) TDP1MAPTALDH1A1KDM4EL3MBTL1
SCHEMBL10582451 0.82 TDP1 (0.53) TDP1MAPTALDH1A1KDM4EL3MBTL1
SCHEMBL9691466 0.82 TDP1 (0.53) TDP1MAPTALDH1A1KDM4EL3MBTL1
SCHEMBL2081030 0.79 GABRA1 (0.51) TDP1MAPTALDH1A1KDM4EL3MBTL1
SCHEMBL2081028 0.79 GABRA1 (0.51) TDP1MAPTALDH1A1KDM4EL3MBTL1
SCHEMBL12784702 0.79 HPGD (0.49) MAPTALDH1A1KDM4EL3MBTL1GAA
SCHEMBL481451 0.76 MAPT (0.65) TDP1MAPTALDH1A1KDM4EL3MBTL1
SCHEMBL165227 0.76 MAPT (0.65) TDP1MAPTALDH1A1KDM4EL3MBTL1
SCHEMBL29419102 0.76 MAPT (0.65) TDP1MAPTALDH1A1KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7897601-B2 Cannabinoid receptor modulators INTERVET, INC. (US) 2011-03-01 US disclosed
US-20070197628-A1 Cannabinoid receptor modulators INTERVET INTERNATIONAL B.V. (NL) 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197628-A1 Cannabinoid receptor modulators CNR1, CNR2, GPR18 TDP1 4156/4885MAPT 1582/4885ALDH1A1 1999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.